Clinical Trial Update: Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) - [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing paclitaxel-releasing balloon catheter system with everolimus-eluting stent for in-stent restenosis lesions; current status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• everolimus-eluting stent system
• paclitaxel-releasing balloon catheter system

Snippet

Sponsor: Seoul National University Hospital | Conditions: In-stent Restenosis Lesion | Phase 4 | Status: UNKNOWN